Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,555.41
(
-0.77%
)
US TECH 100
23,469.60
(
-1.06%
)
Dow Jones
45,792.99
(
-0.50%
)
Brent Oil
106.43
(
1.92%
)
Bitcoin
69,873.28
(
-0.04%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: mcbio post# 144186

Wednesday, 06/20/2012 10:18:14 PM

Wednesday, June 20, 2012 10:18:14 PM

Post# of 257262
i agree but prodromal is better than mild to moderate. IF there is a sign of clinical efficacy in the mild subset of bapineuzumab or solanezumab, then prodromal may prove successful
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today